[go: up one dir, main page]

WO2013100585A3 - Adonis amurensis extract or anti-cancer composition using same as an active ingredient - Google Patents

Adonis amurensis extract or anti-cancer composition using same as an active ingredient Download PDF

Info

Publication number
WO2013100585A3
WO2013100585A3 PCT/KR2012/011497 KR2012011497W WO2013100585A3 WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3 KR 2012011497 W KR2012011497 W KR 2012011497W WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
active ingredient
cancer composition
adonis amurensis
amurensis extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/011497
Other languages
French (fr)
Korean (ko)
Other versions
WO2013100585A2 (en
Inventor
함영민
김길남
정용환
윤원종
박수영
오대주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JEJU TECHNOPARK
Original Assignee
JEJU TECHNOPARK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JEJU TECHNOPARK filed Critical JEJU TECHNOPARK
Priority to JP2014549998A priority Critical patent/JP2015503551A/en
Priority to CN201280064752.3A priority patent/CN104220063B/en
Publication of WO2013100585A2 publication Critical patent/WO2013100585A2/en
Publication of WO2013100585A3 publication Critical patent/WO2013100585A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to an Adonis amurensis extract showing anti-cancer activity in cell and animal experiments, and an anti-cancer composition using the same as an active material.
PCT/KR2012/011497 2011-12-26 2012-12-26 Adonis amurensis extract or anti-cancer composition using same as an active ingredient Ceased WO2013100585A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014549998A JP2015503551A (en) 2011-12-26 2012-12-26 Anti-cancer agent composition using the extract of Myxomycetum or its active substance
CN201280064752.3A CN104220063B (en) 2011-12-26 2012-12-26 Utilize the anti-cancer agent composition of thin Herba Adonidis extract or its active substance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0142072 2011-12-26
KR20110142072 2011-12-26

Publications (2)

Publication Number Publication Date
WO2013100585A2 WO2013100585A2 (en) 2013-07-04
WO2013100585A3 true WO2013100585A3 (en) 2013-08-22

Family

ID=48698749

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/011497 Ceased WO2013100585A2 (en) 2011-12-26 2012-12-26 Adonis amurensis extract or anti-cancer composition using same as an active ingredient

Country Status (4)

Country Link
JP (1) JP2015503551A (en)
KR (1) KR101530910B1 (en)
CN (1) CN104220063B (en)
WO (1) WO2013100585A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110372808B (en) * 2019-07-30 2020-11-03 玛莉艾丝(广东)生命科技有限公司 Freckle-removing and whitening active polysaccharide and application thereof
CN110343187B (en) * 2019-07-30 2020-07-17 广州市爱百伊生物技术有限公司 Natural polysaccharide and freckle removing and whitening application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (en) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd Bleaching cosmetic
KR20030080459A (en) * 2002-04-08 2003-10-17 송호엽 Diabetic Agents and Manufacturing Methods
KR20110001538A (en) * 2009-06-30 2011-01-06 한국콜마 주식회사 Flower mixture extract having antioxidant and whitening activity, extraction method thereof, and cosmetic composition containing the flower mixture extract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (en) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd Bleaching cosmetic
KR20030080459A (en) * 2002-04-08 2003-10-17 송호엽 Diabetic Agents and Manufacturing Methods
KR20110001538A (en) * 2009-06-30 2011-01-06 한국콜마 주식회사 Flower mixture extract having antioxidant and whitening activity, extraction method thereof, and cosmetic composition containing the flower mixture extract

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KI HWAN, BAE ET AL.: "of angiogenesis inhibitors from Korean plants (1)", KOREAN JOURNAL OF PHARMACOGNOSY, vol. 31, no. 3, 2000, pages 320 - 324 *
YOU, YOUNG-JAE ET AL.: "Inhibitory effect of Adonis amurensis components on tube-like formation of human umbilical venous cells", PHYTOTHERAPY RESEARCH, vol. 17, 2003, pages 568 - 570 *

Also Published As

Publication number Publication date
WO2013100585A2 (en) 2013-07-04
CN104220063B (en) 2016-06-08
CN104220063A (en) 2014-12-17
KR101530910B1 (en) 2015-06-23
KR20130074768A (en) 2013-07-04
JP2015503551A (en) 2015-02-02

Similar Documents

Publication Publication Date Title
WO2013102144A3 (en) Ph20 polypeptide variants, formulations and uses thereof
WO2014179629A3 (en) Compositions and methods
WO2012056457A3 (en) Compositions and methods for activating expression by a specific endogenous mirna
EA201500582A1 (en) TRIPLE FUNGICIDAL MIXTURES
HK1208216A1 (en) Drug-conjugates, conjugation methods, and uses thereof
WO2009089494A3 (en) Pharmaceutical compositions
WO2012077077A8 (en) Fungicidal mixtures
MX2016008448A (en) Var2csa-drug conjugates.
WO2012129341A3 (en) Disease detection in plants
CR20140421A (en) PESTICIDE CEPA OF FLAVOBACTERIUM AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES OF THE SAME
HK1202549A1 (en) Donepezil pamoate, preparation method and its use
IL220894A (en) Active ingredient combinations comprising dihydrofuranone derivatives and abamectin, mixture/beneficial species combinations and kit comprising same and uses thereof
FR2967572B1 (en) COSMETIC COMPOSITION COMPRISING POLYPHENOL IN COMBINATION WITH SUGAR
PL2667719T3 (en) Pesticide composition comprising sulphur, an insecticide and an agrochemical excipient.
UA103025C2 (en) Solid pharmaceutical formulation with delayed release
WO2012051328A3 (en) High surface activity pesticides
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2011122872A3 (en) Composition comprising coumestrol or a bean extract containing coumestrol
WO2012002730A3 (en) Skin-whitening and skin-moisturizing composition containing bee venom extracts
ZA201306090B (en) Pesticide composition comprising sulphur,an acaricide and an agrochemical excipient
WO2014044342A8 (en) Magnesium hydroxide carbonate as carrier material in active ingredient-containing preparations
WO2013029011A3 (en) Methods and compositions comprising a c-terminal bax peptide
GT200900006A (en) NEW PIRIDAZINE DERIVATIVES
WO2009047434A3 (en) Use of carriers as preservatives and pharmaceutical composition containing same
IL225440A (en) Cyclohexane derivatives, compositions comprising the same and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014549998

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2